Zealand Pharma A/S/DKr ZEAL
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About Zealand Pharma A/S
Zealand Pharma A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company focuses on developing treatments for gastrointestinal and metabolic diseases, including obesity and diabetes. Its product portfolio includes innovative solutions like dasiglucagon, intended for severe hypoglycemia. Founded in 1998, Zealand Pharma leverages proprietary peptide platforms to address unmet medical needs. The company's strategic positioning involves strong partnerships and collaborations with pharmaceutical companies to advance its products through various stages of clinical development.
Ticker
DKr ZEAL
Sector
Primary listing
CSE
Employees
544
Headquarters
Søborg, Denmark
Website
ZEAL Metrics
BasicAdvanced
kr 20bn
3.19
kr 89.42
0.55
-
Price and volume
Market cap
kr 20bn
Beta
0.55
52-week high
kr 556.00
52-week low
kr 233.50
Average daily volume
594k
Financial strength
Current ratio
37.173
Quick ratio
36.403
Long term debt to equity
2.661
Total debt to equity
2.861
Interest coverage (TTM)
260.34%
Profitability
EBITDA (TTM)
6,799.047
Gross margin (TTM)
99.99%
Net profit margin (TTM)
69.21%
Operating margin (TTM)
73.41%
Effective tax rate (TTM)
7.88%
Revenue per employee (TTM)
kr 16,990,000
Management effectiveness
Return on assets (TTM)
34.72%
Return on equity (TTM)
56.16%
Valuation
Price to earnings (TTM)
3.187
Price to revenue (TTM)
2.174
Price to book
1.39
Price to tangible book (TTM)
1.4
Price to free cash flow (TTM)
3.194
Free cash flow yield (TTM)
31.31%
Free cash flow per share (TTM)
89.224
Growth
Revenue change (TTM)
16,519.65%
Earnings per share change (TTM)
-618.25%
3-year revenue growth (CAGR)
342.49%
10-year revenue growth (CAGR)
47.59%
3-year earnings per share growth (CAGR)
54.39%
10-year earnings per share growth (CAGR)
31.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs